A Win For Marker Therapeutics, Inc.
Fri, Oct 14, 2022 at 09:06 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) rocketted at $0.39, a gain of 25.8%. On Fri, Oct 14, 2022, MRKR:NASDAQ hit a New 2-Week Intraday High of $0.44. From Fri, Sep 30, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Aug 05, 2022 at $0.66 with a volume of 74M+.
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- Creatd Inc. (CRTD:NASDAQ), 69.57%
- Agrify Corporation (AGFY:NASDAQ), 53.75%
- FedNat Holding Company (FNHC:NASDAQ), 48.02%
- IMARA Inc. (IMRA:NASDAQ), 46.9%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 37.04%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 27.72%
- Gravitas Education Holdings Inc ADR (GEHI:NYSE), 27.07%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 25.81%
- Nutanix, Inc. (NTNX:NASDAQ), 24.59%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 23.76%